Glucagon-Like Peptide-1 Limits Myocardial Stunning following Brief Coronary Occlusion and Reperfusion in Conscious Canines

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

1995 • 1,586 citations

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

2002 • 1,295 citations

Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion

2004 • 894 citations

Metabolic Modulation of Acute Myocardial Infarction

1998 • 533 citations

Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy

2004 • 506 citations

Glucose-Insulin-Potassium Therapy for Treatment of Acute Myocardial Infarction

1997 • 475 citations

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

2002 • 472 citations

Fundamentals of Reperfusion Injury for the Clinical Cardiologist

2002 • 435 citations

Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences

1995 • 425 citations

Glucose for the Heart

1999 • 418 citations

Diastolic dysfunction is associatedwith altered myocardial metabolism inasymptomatic normotensive patientswith well-controlled type 2 diabetes mellitus

2003 • 368 citations

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7–37) in normal and diabetic subjects

1994 • 309 citations

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

1994 • 283 citations

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats

2003 • 272 citations

Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction

2003 • 265 citations

Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7?36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships

1995 • 199 citations

Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes

2001 • 181 citations

Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats

1994 • 179 citations

Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting

1997 • 160 citations

Identification of Hibernating Myocardium With Quantitative Intravenous Myocardial Contrast Echocardiography

2003 • 130 citations

Effects of Glucagon-Like Peptide-1 on Islet Function and Insulin Sensitivity in Noninsulin-Dependent Diabetes Mellitus¹

1997 • 129 citations

Mechanisms of postischemic contractile dysfunction

1999 • 103 citations

Insulin therapy as an adjunct toreperfusion after acute coronary ischemia

2003 • 103 citations

Effects of Glucagon-Like Peptide-1 on Islet Function and Insulin Sensitivity in Noninsulin-Dependent Diabetes Mellitus

1997 • 98 citations

Glucagon-like peptide-1 (7–36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium

2003 • 95 citations

Glucagon‐like peptide‐1 (GLP‐1): a trial of treatment in non‐insulin‐dependent diabetes mellitus

1997 • 86 citations

Insulinotropic Hormone Glucagon-Like Peptide-1-(7–37) Appears Not to Augment Insulin-Mediated Glucose Uptake in Young Men during Euglycemia¹

1998 • 81 citations

Distribution of GLP‐1 and PACAP receptors in human tissues

1996 • 75 citations

Myocardial blood flow, function, and metabolism in repetitive stunning.

2000 • 71 citations

Insulinotropic Hormone Glucagon-Like Peptide-1-(7-37) Appears Not to Augment Insulin-Mediated Glucose Uptake in Young Men during Euglycemia

1998 • 66 citations

Delayed Enhanced Nitric Oxide–Mediated Coronary Vasodilation Following Brief Ischemia and Prolonged Reperfusion in Conscious Dogs

1997 • 58 citations

Novel mechanisms mediating stunned myocardium.

2003 • 55 citations

Cardiovascular and pancreatic endocrine responses to glucagon‐like peptide‐1(7–36) amide in the conscious calf

1997 • 53 citations

Metabolic support for the postischaemic heart

1995 • 46 citations

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

2002 • 36 citations

Proof that glucose-insulin-potassium provides metabolic protection of ischaemic myocardium?

1999 • 35 citations

Left ventricular systolic dysfunction precedes diastolic dysfunction during myocardial ischemia in conscious dogs

1994 • 32 citations

The benefits of glucose-insulin-potassium for acute myocardial infarction (and some concerns)

2003 • 29 citations

Brief Increase in Carbohydrate Oxidation After Reperfusion Reverses Myocardial Stunning in Conscious Pigs

2002 • 29 citations

Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO

2001 • 25 citations

Myocardial glucose uptake after dobutamine stress in chronic hibernating swine myocardium

2003 • 17 citations

Myocardial stunning: an experimental act with a large clinical audience.

2003 • 7 citations